Researchers report the development of nanoparticles made from repetitively branched molecules that could effectively deliver small RNAs to liver cancer cells with low toxicity to normal tissue, and that extended survival by up to 40 days when used in conjunction with a tumor-suppressing microRNA in a mouse model of aggressive, late-stage liver cancer.
↧